Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lasse Myllylahti"'
Publikováno v:
Thrombosis Journal, Vol 20, Iss 1, Pp 1-8 (2022)
Abstract Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is triggered by nCOV-19 adenovirus-vectored vaccines against SARS-CoV2. Pathogenesis has been mainly related to platelet activation via PF4-reactive antibodies that act
Externí odkaz:
https://doaj.org/article/6020bc5a5fea4dd496e803ade3b48a6c
Autor:
Lasse Myllylahti MD, Jussi Ropponen MD, PhD, Mikko Lax MD, Riitta Lassila MD, PhD, Antti I. Nykänen MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Objectives Chronic thromboembolic pulmonary hypertension (CTEPH) is associated with thrombotic states including elevated coagulation factor VIII (FVIII). Pulmonary endarterectomy (PEA) is the main treatment for CTEPH, and efficient anticoagulation is
Externí odkaz:
https://doaj.org/article/5d4bfe9593564143ba6a4b55b9286a22
Publikováno v:
Thrombosis Journal
Thrombosis Journal, Vol 20, Iss 1, Pp 1-8 (2022)
Thrombosis Journal, Vol 20, Iss 1, Pp 1-8 (2022)
Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is triggered by nCOV-19 adenovirus-vectored vaccines against SARS-CoV2. Pathogenesis has been mainly related to platelet activation via PF4-reactive antibodies that activate pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d547a8e4fcea6716ed1299b18f0bbf3
https://pubmed.ncbi.nlm.nih.gov/35120527
https://pubmed.ncbi.nlm.nih.gov/35120527